Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3643757 | 1.00 | MEN1 (0.30) | MEN1ALDH1A1GAAKMT2ATRPA1 | |
| SCHEMBL44493 | 1.00 | MEN1 (0.30) | MEN1ALDH1A1GAAKMT2ATRPA1 | |
| SCHEMBL28910128 | 0.91 | — | — | |
| Acetic Acid SCHEMBL9788861 | 0.86 | NOTUM (0.37) | MEN1KMT2A | |
| SCHEMBL10463884 | 0.82 | HPGD (0.35) | MEN1ALDH1A1KMT2A | |
| SCHEMBL3094885 | 0.82 | HTR2C (0.53) | — | |
| SCHEMBL7619455 | 0.82 | GAA (0.36) | MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL7916390 | 0.82 | CYP2B6 (0.35) | — | |
| Benzothiophene SCHEMBL29032817 | 0.80 | — | — | |
| SCHEMBL6200557 | 0.79 | MEN1 (0.35) | MEN1ALDH1A1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3885337-B1 | FTO INHIBITORS | NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) | 2025-01-15 | — | — | EP | claimed |
| EP-4486395-A1 | PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE | Atoms for Cure GmbH (DE) | 2025-01-08 | — | — | EP | claimed |
| US-20240366807-A1 | RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN | TRUSTEES OF TUFTS COLLEGE | 2024-11-07 | — | — | US | claimed |
| EP-4452326-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2024-10-30 | — | — | EP | claimed |
| EP-4281119-A1 | PRECURSOR MARKER AND RADIOTRACER FOR NUCLEAR-MEDICAL DIAGNOSIS AND THERAPY OF BONE-METASTATIC PROSTATE CANCER | SCV - SpezialChemikalienVertrieb GmbH (DE) | 2023-11-29 | — | — | EP | claimed |
| WO-2023165987-A1 | PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE | Atoms for Cure GmbH (DE) | 2023-09-07 | — | — | WO | claimed |
| WO-2023118195-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2023-06-29 | — | — | WO | claimed |
| WO-2023023261-A1 | RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN | TRUSTEES OF TUFTS COLLEGE (US) | 2023-02-23 | — | — | WO | claimed |
| WO-2022157277-A1 | PRECURSOR MARKER AND RADIOTRACER FOR NUCLEAR-MEDICAL DIAGNOSIS AND THERAPY OF BONE-METASTATIC PROSTATE CANCER | SCV - SpezialChemikalienVertrieb GmbH (DE) | 2022-07-28 | — | — | WO | claimed |
| US-20250282621-A1 | CARBON NANOTUBE COMPOSITE COMPRISING MECHANICAL L IGANDS | NANOCORE APS (DK) | 2025-09-11 | — | — | US | disclosed |
| US-12227625-B2 | Composite materials comprising mechanical ligands | NANOCORE APS (DK) | 2025-02-18 | — | — | US | disclosed |
| EP-4486395-A1 | PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE | Atoms for Cure GmbH (DE) | 2025-01-08 | — | — | EP | disclosed |
| US-20240366807-A1 | RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN | TRUSTEES OF TUFTS COLLEGE | 2024-11-07 | — | — | US | disclosed |
| EP-3850680-B1 | ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-11-06 | — | — | EP | disclosed |
| EP-4119598-A1 | NANOCOMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS | Nanocore ApS (DK) | 2023-01-18 | — | — | EP | disclosed |
| WO-2023275051-A1 | RING-OPENING METATHESIS REACTIONS FOR PREPARATION OF CARBON NANOTUBE COMPOSITES | NANOCORE APS (DK) | 2023-01-05 | — | — | WO | disclosed |
| WO-2023275063-A1 | ELECTROSPINNING OF CARBON NANOTUBE COMPOSITES | NANOCORE APS (DK) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022157277-A1 | PRECURSOR MARKER AND RADIOTRACER FOR NUCLEAR-MEDICAL DIAGNOSIS AND THERAPY OF BONE-METASTATIC PROSTATE CANCER | SCV - SpezialChemikalienVertrieb GmbH (DE) | 2022-07-28 | — | — | WO | disclosed |
| EP-4029904-A1 | DESIGN OF COMPOSITE MATERIALS WITH DESIRED CHARACTERISTICS | Nanocore ApS (DK) | 2022-07-20 | — | — | EP | disclosed |
| EP-3737711-B1 | COMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS | NANOCORE APS (DK) | 2022-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366807-A1 | RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN | FAP, FIBP, FRS2 | MEN1 1909/4885ALDH1A1 1725/4885GAA 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.